metadata toggle
Loading image navigation...
No image index could be found for this publication.
Close this Panel
Significant changes
Change titleChange detailChange dateDatasheetCreated by
Bovalto Respi IntranasalAdverse Event section text "Very commonly, a slight and transient nasal discharge may occur the first three days after vaccination without any adverse consequence for in-contact animals.The local reactions observed and their frequency relate to observations following administration of an overdose under controlled laboratory conditions" replaced by "A hypersensitivity reaction may very rarely occur, which may require appropriate symptomatic treatment."

Overdose text "No adverse effect other than that mentioned in Adverse Reactions" replaced by "A slight and transient nasal discharge was observed the first three days after the administration of an overdose without any adverse consequence for in-contact animals."		25 June 2021Bovalto Respi Intranasal [GB]boehringer-everard
Bovalto Respi IntranasalAddition of a 10-dose presentation.03 September 2021Bovalto Respi Intranasal [GB]boehringer-everard
Bovalto Respi IntranasalAddition of a 1-dose presentation impacting Section 6.5. Update to new GB SPC template - change to Section 3.10, formatting change to Section 3.6, previous UK licence split to GB and NI licences. This is the GB datasheet with the new MA number.30 December 2022Bovalto Respi Intranasal [GB]boehringer-everard
Change titleChange detailChange dateDatasheetCreated by